I don't know how Aus works, but, in the U.S., we need a much more serious right-to-try regime, particularly for fatal diseases like GBM. The FDA is way too slow and paternalistic, a topic that I've been writing about: https://jakeseliger.com/2024/01/29/the-dead-and-dying-at-the... and https://jakeseliger.com/2023/07/22/i-am-dying-of-squamous-ce... because I'm dying from a squamous cell carcinoma infestation that, it turns out, should be much more treatable than it has been so far.

For example, MCLA-158 / petosemtamab should, based on existing phase 1a and 1b data, be approved: https://beta.clinicaltrials.gov/study/NCT03526835. But, from what I understand, the FDA is going to make Merus proceed with phase 3 trials, despite the incredibly positive phase 1b and 2 data. Madness.

The FDA killed during the pandemic: https://moreisdifferent.blog/p/fda-devastation-during-the-pa... and continues to kill today.

And they worried the experiment could kill him faster.

It's a reasonable trade-off to decide to take the risk.

Immunotherapy drugs are quite toxic, especially when mixed, so he could be poisoned

I wonder which the author is talking about, because e.g. pembrolizumab (Keytruda) is not. I assume the author isn't talking about e.g. CAR-T therapies?

If you're in the US and know someone with GBM, look into DCVax: https://www.uclahealth.org/departments/neurosurgery/phase-ii....